Chapter 24 – Part D: Liver, Lipoproteins, Appetite & Thermoregulation
Slide 69 – Introduction to Part D
Covers Chapter 24, slides 69–92 (PDF on Learn)
Topics: liver metabolism, cholesterol metabolism, lipoprotein transport, regulation of food intake, regulation of body temperature
Slide 70 – Liver Metabolism: General Scope
Hepatocytes perform > 500 metabolic functions → most versatile metabolic tissue
Involved in metabolism of: carbohydrates, fats, proteins, vitamins, drugs/toxins
Also essential for vitamin & iron storage, alcohol/drug inactivation, bilirubin & hormone processing
Slide 71 – Carbohydrate Roles of the Liver
Converts galactose & fructose → glucose
"Glucose-buffer" function: stores glucose as glycogen; releases during fasting
Gluconeogenesis: generates new glucose during prolonged fasting/starvation
Converts excess glucose → fatty acids → triglycerides for storage (hepatic & adipose)
Slide 72 – Hepatic Fat Metabolism
Major site of β-oxidation → acetyl-CoA production (ATP or biosynthesis precursor)
Converts excess acetyl-CoA → ketone bodies (alternate fuel in starvation/diabetes)
Temporary triglyceride storage (secondary to adipocytes)
Synthesises ALL circulating lipoproteins (chylomicron remnants, VLDL, LDL, HDL)
De-novo cholesterol synthesis from acetyl-CoA → bile salts, steroid hormones
Slide 73 – Hepatic Protein Metabolism
Oxidative deamination of amino acids (removes NH₃ for urea cycle)
Transaminase reactions interconvert amino/keto acids (AA synthesis or gluconeogenesis)
Urea formation (detoxifies NH₃ → kidneys)
Synthesis of most plasma proteins (albumin, α/β-globulins, clotting factors)
• Exception: γ-globulins produced by plasma (B) cells
Slide 74 – Storage & Biotransformation Functions
Vitamin stores: Vitamin A (1–2 yr supply), Vitamin D, Vitamin B₁₂
Iron stored as ferritin/hemosiderin (readily released for haemoglobin synthesis)
Biotransformation: Phase I & II drug metabolism, alcohol dehydrogenase & CYP system
Bilirubin conjugation (heme breakdown → bile excretion)
Metabolises steroid & peptide hormones to excretable forms
Slide 75 – Cholesterol: Functions & Sources
Structural component of plasma membranes; precursor of bile salts, steroid hormones, Vitamin D
Diet supplies ≈ 15 %; liver de-novo synthesis ≈ 85 % (from acetyl-CoA)
Loss: conversion to bile salts → some lost in faeces (enterohepatic inefficiency)
Insoluble in water → must travel in lipoproteins
Slide 76 – Basic Lipoprotein Structure
Spherical particle: phospholipid monolayer (hydrophilic heads outward) + unesterified cholesterol + apolipoproteins (Apo)
Hydrophobic core: triglycerides + cholesterol esters (CE)
Apolipoproteins = address tags + enzyme cofactors (e.g., ApoB-100, ApoA-I)
Slide 77 – Four Principal Lipoprotein Classes
Class | Major Apo | Diameter | Content (% by weight) | Origin | Primary Cargo |
|---|---|---|---|---|---|
Chylomicron | ApoB-48 | Largest | TG 80-95 %; CE 2-7 %; PL 3-6 %; Pr 1-2 % | Intestine | dietary TG → tissues |
VLDL | ApoB-100 | Δ↓ | TG 55-65 %; PL 15-20 %; CE 10-15 %; Pr 5-10 % | Liver | endogenous TG |
LDL | ApoB-100 | Δ↓↓ | CE 45-50 %; PL 20 %; TG 10 %; Pr 25 % | From VLDL remnant | cholesterol → tissues |
HDL | ApoA-I/II | Smallest | Pr 45-50 %; PL 30 %; CE 20 %; TG 5 % | Liver, intestine | cholesterol ↺ liver/steroid glands |
(Noscent HDL = lipid-poor; matures after CE uptake via LCAT) |
Slide 78 – Metabolic Relationships
Intestinal chylomicrons deliver dietary TG; remnants cleared by liver
Liver packages TG as VLDL → peripheral tissues; LPL unloads TG → converts VLDL → IDL → LDL
LDL delivers cholesterol; cells uptake via LDL-R, then lysosomal hydrolysis
HDL (good) scavenges excess cholesterol → returns to liver or steroidogenic organs
Slide 79 – Cellular Handling of LDL
LDL binds LDL-R → endocytosis → lysosome
Releases: cholesterol, FA, amino acids
Intracellular cholesterol:
• ↓ LDL-R synthesis (feedback)
• ↓ HMG-CoA reductase (↓ de-novo synthesis)
• ↑ ACAT activity → cholesterol-ester storage
Slide 80 – HDL Loading & LCAT
Liver secretes collapsed “noscent” HDL (ApoA-I + PL)
Lecithin-Cholesterol Acyl-Transferase (LCAT) catalyses cholesterol → CE (hydrophobic) → migrates to HDL core
CETP may swap CE ↔ TG with VLDL/LDL
Mature HDL delivers CE to liver (SR-B1 receptor) or endocrine tissues
Slide 81 – Plasma Cholesterol, Lipoproteins & Disease
Total cholesterol > associated with atherosclerosis, MI, stroke
HDL > = protective; LDL > = risk
“You can’t have HDL too high, nor LDL too low” (within physiologic limits)
Lipoprotein(a) [Lp(a)] = ApoB-100 + Apo(a) → highly atherogenic; elevates MI risk ×2 (< 55 y males ~ 20 % prevalence)
Slide 82 – Dietary & Metabolic Modifiers of Cholesterol
High dietary cholesterol ↓ hepatic synthesis, but compensation is incomplete
Saturated fats ↑ hepatic cholesterol synthesis & ↓ excretion
Unsaturated fats (olive/vegetable oil) ↓ LDL, ↑ cholesterol excretion as bile salts
Trans-fats (hydrogenated oils) ↑ LDL, ↓ HDL → worst profile
ω-3 PUFA (cold-water fish): ↓ triglycerides, anti-arrhythmic, ↓ platelet aggregation (eicosanoid modulation)
Slide 83 – Regulation of Food Intake: Hypothalamic Arcuate Nucleus
Two reciprocal neuronal sets:
NPY/AgRP neurons (orexigenic)
• Release Neuropeptide Y & Agouti-related peptide
• ↑ Appetite, ↓ metabolism (energy conservation)POMC/CART neurons (anorexigenic)
• Release α-MSH (from POMC) & CART
• ↑ Satiety, ↑ energy expenditure
Slide 84 – Hormonal & Neural Inputs Controlling Appetite
Short-term (meal-to-meal):
Gastric distension → vagal afferents → NTS → activates POMC/CART (satiety)
Nutrients (glucose, AA, FA) → same pathway → satiety
Gut hormones:
• CCK, insulin, GLP-1 → satiety (↑ POMC/CART)
• Ghrelin, glucagon, epinephrine → hunger (↑ NPY/AgRP)
Long-term:Leptin (adipocytes) & insulin (pancreas) directly ↑ POMC/CART & ↓ NPY/AgRP
Slide 85 – Obesity & Body Mass Index (BMI)
Formula (imperial units):
Interpretation:
Normal: 20 – 25
Overweight: 25 – 30
Obese: > 30 (under 20 may indicate under-nutrition)
Health Risks of Obesity:↑ Atherosclerosis, Type 2 Diabetes, HTN, CAD, osteoarthritis
Prevalence rising: overweight children ↑ from 5 % → 18 % in 20 yr
Slide 86 – Heat Balance Overview
Resting heat producers: liver, heart, brain, endocrine organs
During exercise: skeletal muscle heat ↑ 30-40 ×
Core set-point ≈ (98.6 °F) for optimal enzyme activity
Slide 87 – Heat Production Mechanisms
Basal Metabolic Rate (BMR) modulation (thyroxine, epinephrine)
Muscular activity: shivering thermogenesis
Non-shivering (hormonal) thermogenesis: catecholamines, thyroxine ↑ mitochondrial uncoupling & futile cycles
Slide 88 – Heat Loss Mechanisms & Percent Contributions
Radiation (~ 50 %) – infrared emission to environment
Conduction – direct contact heat transfer (e.g., cold metal bar)
Convection (~ 20 %) – warm air rises, cool air replaces
Evaporation (~ 30 % total)
• Insensible (10 %): continuous evaporation from lungs/skin
• Sensible: sweating; efficiency ↓ with ↑ humidity
Slide 89 – Core vs Shell Temperature & Blood Flow
Core (cranial, thoracic, abdominal cavities) tightly regulated ~ 37 °C
Shell (skin, extremities) may vary 20 – 40 °C
Blood redistributes heat: vasoconstriction conserves; vasodilation dissipates
Slide 90 – Neural Thermoregulation
Key Hypothalamic Centers:
Pre-optic Area (POA): activates heat-loss (vasodilation, sweating)
Posterior Hypothalamus: activates heat-gain (vasoconstriction, shivering)
Sensors:Peripheral thermoreceptors (skin) – anticipatory feed-forward
Central thermoreceptors (core) – dominant feedback controller
Slide 91 – Detailed Effector Responses
Heat-Promoting:
Sympathetic cutaneous vasoconstriction
Non-shivering thermogenesis (norepi/epi fuel cycling)
Shivering (involuntary skeletal muscle contraction)
Thyroxine ↑ during winter → higher BMR (“Canadian gene”)
Heat-Loss:Cutaneous vasodilation
Sweating (when ambient > 33 °C)
Behavioral: reduce activity, seek shade/AC, loose-light clothing
Slide 92 – Hyperthermia: Heat Exhaustion vs Heat Stroke
Heat-Induced Exhaustion:
Vigorous activity + profuse sweating
Dehydration → low BP, mental confusion, fainting
Heat Stroke (medical emergency):When cooling/re-hydration inadequate, mechanisms fail
Core T ≈ or higher
Skin hot & dry (sweating stops to conserve blood volume)
Rising T ↑ metabolic rate (enzyme inefficiency) → vicious cycle
Risk of multi-organ damage & death without rapid intervention
End of Part D notes (Slides 69–92).